Business Description
Johnson Chemical Pharmaceutical Works Co
ISIN : TW0004747001
Total Employee Number:
172Description
Johnson Chemical Pharmaceutical Works Co is engaged in the manufacturing of pharmaceutical ingredients, importing and selling pharmaceutical materials and products. It manufactures drugs in a variety of forms, including solid dosage forms, capsules (soft/hard), tablets (sugar/film-coated), powder and granule, as well as nasal sprays. It offers products in therapeutic areas including the central nervous system, respiratory, cardiovascular, gastrointestinal, and endocrine system, vitamins, anti-inflammatory, cough and cold, and pain relievers. Its revenue mainly comes from medical product sales.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.41 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.15 | |||||
Debt-to-EBITDA | 2.98 | |||||
Interest Coverage | 19.52 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 8.12 | |||||
Beneish M-Score | -2.71 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6.4 | |||||
3-Year EBITDA Growth Rate | -14.8 | |||||
3-Year EPS without NRI Growth Rate | -18.4 | |||||
3-Year FCF Growth Rate | -43.4 | |||||
3-Year Book Growth Rate | 12.7 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 56.79 | |||||
9-Day RSI | 45.91 | |||||
14-Day RSI | 42.02 | |||||
3-1 Month Momentum % | -0.73 | |||||
6-1 Month Momentum % | -9.08 | |||||
12-1 Month Momentum % | -12.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.79 | |||||
Quick Ratio | 3.3 | |||||
Cash Ratio | 3 | |||||
Days Inventory | 168.13 | |||||
Days Sales Outstanding | 61.61 | |||||
Days Payable | 47.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.1 | |||||
Dividend Payout Ratio | 1.5 | |||||
3-Year Dividend Growth Rate | 10 | |||||
Forward Dividend Yield % | 2.1 | |||||
5-Year Yield-on-Cost % | 2.2 | |||||
3-Year Average Share Buyback Ratio | -11.1 | |||||
Shareholder Yield % | 1.39 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 40.08 | |||||
Operating Margin % | 12.83 | |||||
Net Margin % | 9.39 | |||||
EBITDA Margin % | 15.35 | |||||
FCF Margin % | 1.34 | |||||
OCF Margin % | 12.59 | |||||
ROE % | 3.14 | |||||
ROA % | 2.67 | |||||
ROIC % | 7.47 | |||||
3-Year ROIIC % | -3.12 | |||||
ROC (Joel Greenblatt) % | 9.09 | |||||
ROCE % | 3.86 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 42.7 | |||||
PE Ratio without NRI | 42.84 | |||||
Shiller PE Ratio | 23.19 | |||||
Price-to-Owner-Earnings | 87.87 | |||||
PS Ratio | 4.03 | |||||
PB Ratio | 1.33 | |||||
Price-to-Tangible-Book | 1.33 | |||||
Price-to-Free-Cash-Flow | 314.16 | |||||
Price-to-Operating-Cash-Flow | 32.19 | |||||
EV-to-EBIT | 54.39 | |||||
EV-to-EBITDA | 41.74 | |||||
EV-to-Revenue | 6.41 | |||||
EV-to-FCF | 477.18 | |||||
Price-to-GF-Value | 0.83 | |||||
Price-to-Projected-FCF | 1.47 | |||||
Price-to-Median-PS-Value | 1.37 | |||||
Price-to-Graham-Number | 1.59 | |||||
| Price-to-Net-Current-Asset-Value | 2.11 | |||||
| Price-to-Net-Cash | 2.95 | |||||
Earnings Yield (Greenblatt) % | 1.84 | |||||
FCF Yield % | 0.17 | |||||
Forward Rate of Return (Yacktman) % | 3.42 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Johnson Chemical Pharmaceutical Works Co Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 569.772 | ||
| EPS (TTM) (NT$) | 1.17 | ||
| Beta | 0.4718 | ||
| 3-Year Sharpe Ratio | -1.21 | ||
| 3-Year Sortino Ratio | -1.41 | ||
| Volatility % | 26.77 | ||
| 14-Day RSI | 42.02 | ||
| 14-Day ATR (NT$) | 1.178306 | ||
| 20-Day SMA (NT$) | 50.32 | ||
| 12-1 Month Momentum % | -12.74 | ||
| 52-Week Range (NT$) | 48.1 - 80.4 | ||
| Shares Outstanding (Mil) | 90.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Johnson Chemical Pharmaceutical Works Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Johnson Chemical Pharmaceutical Works Co Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 1.050000 Cash Dividend | 2026-07-06 | 50.20 (+1.41%) | ||
| TWD 1.750000 Cash Dividend | 2025-06-26 | 63.40 (-0.94%) | ||
| 1.125:1 Stock Split | 2014-07-30 | 57.33 (+0.00%) | ||
| 1.125:1 Stock Split | 2013-07-18 | 55.89 (+0.00%) | ||
| 1.125:1 Stock Split | 2012-07-30 | 20.19 (+0.00%) | ||
| 1.06667:1 Stock Split | 2011-08-04 | -- |
Show
Entries
Johnson Chemical Pharmaceutical Works Co Frequently Asked Questions
What is Johnson Chemical Pharmaceutical Works Co(ROCO:4747)'s stock price today?
The current price of ROCO:4747 is NT$49.95. The 52 week high of ROCO:4747 is NT$80.40 and 52 week low is NT$48.10.
When is next earnings date of Johnson Chemical Pharmaceutical Works Co(ROCO:4747)?
The next earnings date of Johnson Chemical Pharmaceutical Works Co(ROCO:4747) is .
Does Johnson Chemical Pharmaceutical Works Co(ROCO:4747) pay dividends? If so, how much?
The Dividend Yield %  of Johnson Chemical Pharmaceutical Works Co(ROCO:4747) is 2.1% (As of Today), Highest Dividend Payout Ratio of Johnson Chemical Pharmaceutical Works Co(ROCO:4747) was 1.5. The lowest was 0.6. And the median was 0.89. The  Forward Dividend Yield % of Johnson Chemical Pharmaceutical Works Co(ROCO:4747) is 2.1%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Johnson Chemical Pharmaceutical Works Co
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers